# Disulfiram in Recurrent Glioblastoma

> **NCT02678975** · PHASE2,PHASE3 · COMPLETED · sponsor: **Sahlgrenska University Hospital** · enrollment: 88 (actual)

## Conditions studied

- Glioma
- Glioblastoma

## Interventions

- **DRUG:** Disulfiram
- **DIETARY_SUPPLEMENT:** Copper
- **DRUG:** Alkylating Agents

## Key facts

- **NCT ID:** NCT02678975
- **Lead sponsor:** Sahlgrenska University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2021-01-15
- **Final completion:** 2021-01-15
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2021-03-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02678975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02678975, "Disulfiram in Recurrent Glioblastoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02678975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*